Kalos Management, Inc. Jazz Pharmaceuticals PLC Transaction History

Kalos Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Jun 21, 2022	SELL	$129.64 - $160.7 $951,687 - $1.18 Million	-7,341 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$119.87 - $145.67 $33,803 - $41,078	282 Added 3.99%	7,341 $978,000
Q3 2021 Nov 10, 2021	SELL	$128.64 - $184.79 $56,858 - $81,677	-442 Reduced 5.89%	7,059 $941,000
Q2 2021 Aug 11, 2021	BUY	$160.2 - $186.42 $29,636 - $34,487	185 Added 2.53%	7,501 $1.13 Million
Q1 2021 May 13, 2021	SELL	$150.19 - $173.5 $34,693 - $40,078	-231 Reduced 3.06%	7,316 $1.27 Million
Q4 2020 Feb 11, 2021	SELL	$140.71 - $165.05 $7,598 - $8,912	-54 Reduced 0.71%	7,547 $1.26 Million
Q3 2020 Nov 12, 2020	BUY	$105.46 - $144.13 $4,323 - $5,909	41 Added 0.54%	7,601 $1.14 Million
Q2 2020 Aug 13, 2020	SELL	$95.68 - $121.88 $14,352 - $18,282	-150 Reduced 1.95%	7,560 $927,000
Q1 2020 May 13, 2020	BUY	$87.74 - $152.74 $676,475 - $1.18 Million	7,710 New	7,710 $881,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kalos Management, Inc. with notifications on news.